M&A / Deals Merck KGaA acquires JSR chromatography business Pharmaceutical Business ReviewThis follows the company's signing of a definitive agreement in October 2025 to acquire the business.M&A / DealsRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Business Review This follows the company’s signing of a definitive agreement in October 2025 to acquire the business. M&A / DealsRead full story Post navigation Previous: Biocytogen and Sihuan partner to advance new therapeutics for weight lossNext: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26 Related Stories M&A / Deals Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B pharminent May 13, 2026 M&A / Deals BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal pharminent May 12, 2026 M&A / Deals Cellular Intelligence scoops up Novo’s Parkinson’s therapy pharminent May 12, 2026
